Regeneron Pharmaceuticals (REGN) EPS (Basic) (2009 - 2026)
Regeneron Pharmaceuticals (REGN) posted EPS (Basic) of $12.62 for Q2 2026, up 80.42% on a QoQ basis from $6.99 in Q1 2026, and down 4.72% year-over-year from $13.24 in Q2 2025.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) EPS (Basic) (2009 - 2026) Analysis & Trends
Regeneron Pharmaceuticals has reported EPS (Basic) for 18 years, with the latest figure at $12.62 in Q2 2026.
- On a quarterly basis, EPS (Basic) fell 4.72% year-over-year to $12.62 in Q2 2026; TTM through Jun 2026 was $42.11, a 0.74% decrease from a year earlier, with the FY2025 full-year figure at $43.07, up 5.31% from the prior year.
- EPS (Basic) was $12.62 for Q2 2026 at Regeneron Pharmaceuticals, up from $6.99 in the prior quarter.
- The five-year high for EPS (Basic) was $14.09 in Q3 2025, with the low at $6.7 in Q1 2024.
- Average EPS (Basic) over 5 years is $10.05, with a median of $9.3 recorded in 2022.
- The sharpest annual moves came in 2022 and 2024: EPS (Basic) slumped 73.24% in 2022, then surged 46.4% in 2024.
- Over 5 years, EPS (Basic) stood at $11.18 in 2022, then slipped by 2.77% to $10.87 in 2023, then declined by 21.74% to $8.51 in 2024, then fell by 5.06% to $8.07 in 2025, then jumped by 56.24% to $12.62 in 2026.
- The last three EPS (Basic) figures came in at $12.62 (Q2 2026), $6.99 (Q1 2026), and $8.07 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 0.66 |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -0.06 |
| 10 | BioNTech SE | 26.24 Bn | 12.58 Bn | 10.00 Mn | -4.31 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.62 |
| Mar 31, 2026 | 6.99 |
| Dec 31, 2025 | 8.07 |
| Sep 30, 2025 | 14.09 |
| Jun 30, 2025 | 13.24 |
| Mar 31, 2025 | 7.58 |
| Dec 31, 2024 | 8.51 |
| Sep 30, 2024 | 12.40 |
| Jun 30, 2024 | 13.25 |
| Mar 31, 2024 | 6.70 |
| Dec 31, 2023 | 10.87 |
| Sep 30, 2023 | 9.48 |
| Jun 30, 2023 | 9.05 |
| Mar 31, 2023 | 7.64 |
| Dec 31, 2022 | 11.18 |
| Sep 30, 2022 | 12.31 |
| Jun 30, 2022 | 7.90 |
| Mar 31, 2022 | 9.12 |
| Dec 31, 2021 | 21.09 |
| Sep 30, 2021 | 15.37 |